Neflamapimod
Nonfluent Variant Primary Progressive Aphasia (Nfvppa)
Phase II
Recruiting
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
Jun 13, 2025
―
Neflamapimod
Moderate To Severe Acute Ischaemic Stroke, Ischaemic Stroke
Phase II
Recruiting
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
May 05, 2025
―
Neflamapimod
Dementia With Lewy Bodies (Dlb)
Phase II
Active Not Recruiting
A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Jan 23, 2025
―
Neflamapimod
Dementia With Lewy Bodies
Phase II
Completed
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Apr 12, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does CervoMed (DP8) have in its pipeline
DP8 is currently developing the following drugs: Neflamapimod, Neflamapimod, Neflamapimod. These drug candidates are in various stages of clinical development as the company works toward FDA approval.